Policy & Caregiving
Policy & Caregiving
In 2024, two bipartisan federal laws reshaped the national approach to Alzheimer's research and care. Here's what the NAPA Reauthorization Act and the Alzheimer's Accountability and Investment Act actually change for families.
In October 2024, Congress passed two landmark, bipartisan laws addressing Alzheimer's disease and related dementias: the NAPA Reauthorization Act (P.L. 118-92) and the Alzheimer's Accountability and Investment Act (P.L. 118-93). Together, they extend more than a decade of federal momentum on Alzheimer's research, care systems, and caregiver support. With an estimated 6.9 million Americans aged 65 and older living with Alzheimer's, and care costs projected to hit $360 billion in 2024, the stakes for families are enormous. This article breaks down what each law actually does, why lawmakers acted now, and what it practically means for seniors and the caregivers supporting them.
Congress extended the National Alzheimer's Plan through 2035 and locked in direct NIH research funding requests, aiming to sustain research, expand federal coordination, and support caregivers amid a growing dementia care crisis.
Signed into law in October 2024 as P.L. 118-92, the NAPA Reauthorization Act builds on the original National Alzheimer's Project Act of 2011, which first transformed how the federal government coordinates its response to dementia. Introduced as House Bill 619 in the 118th Congress, the reauthorization extends the National Alzheimer's Plan through 2035.
The law refines the plan's scope to prioritize healthy aging and reducing risk factors tied to cognitive decline. It also expands the Advisory Council on Alzheimer's Research, Care, and Services to include the Department of Justice, FEMA, and the Social Security Administration, reflecting how deeply dementia touches legal, emergency management, and benefits systems beyond healthcare alone.
For families, the practical effect is continuity: the federal planning apparatus that shapes research priorities and caregiver resources doesn't lapse or need renegotiation for another decade.
Enacted the same day as P.L. 118-93, this companion law tackles a narrower but consequential problem: how the National Institutes of Health requests money for Alzheimer's research. Starting with fiscal year 2024, the NIH must submit an independent annual budget estimate directly to Congress and the president.
Critically, that estimate is transmitted without alteration by the Department of Health and Human Services or the Advisory Council, removing a layer where funding requests could previously be softened or reshaped for political reasons.
The goal is straightforward: align dollars with what scientists and clinicians say is actually needed to fight Alzheimer's, and make the budget process transparent enough that advocates and families can track whether funding keeps pace with the disease's toll.
The numbers behind these laws are stark. In 2022, Alzheimer's was the seventh leading cause of death in the United States, according to the CDC, with 120,122 deaths recorded that year. The Alzheimer's Association estimates 6.9 million Americans aged 65 and older currently live with the disease.
The financial toll is just as steep. Formal care costs were projected to reach $360 billion in 2024, while family caregivers provided an estimated $350 billion in unpaid care in 2023. Caring.com's 2024 dementia care study found that 75% of dementia caregivers say finances significantly shape whether their loved one receives care at home or in a memory care facility.
Without treatment advances, total dementia care costs could approach $1 trillion by 2050 — a trajectory lawmakers cited as justification for locking in a long-term, well-funded national response rather than revisiting the issue piecemeal.
| Law | Key Provision | Runs Through |
|---|---|---|
| NAPA Reauthorization Act (P.L. 118-92) | Extends National Alzheimer's Plan; adds DOJ, FEMA, SSA to advisory council | 2035 |
| Alzheimer's Accountability and Investment Act (P.L. 118-93) | Requires NIH to submit independent annual budget to Congress | FY2024 onward |
| Original NAPA (P.L. 111-375) | Established the National Alzheimer's Project in 2011 | Superseded by 2024 reauthorization |
Both laws passed with genuine bipartisan backing, an increasingly rare feat in Congress. Senators Susan Collins (R-Maine) and Ed Markey (D-Mass.), along with Representatives Paul Tonko (D-N.Y.) and Chris Smith (R-N.J.), were named as key congressional champions of the legislation.
Behind the scenes, advocacy organizations did much of the groundwork. The Alzheimer's Association and its sister group, the Alzheimer's Impact Movement (AIM), mobilized grassroots supporters, briefed policymakers, and kept pressure on Congress to act before the original National Alzheimer's Project Act's provisions could lapse or lose momentum.
That advocacy infrastructure matters for families too — it's often the same organizations, particularly the Alzheimer's Association, that run the helplines, support groups, and educational resources caregivers rely on day to day.
The NAPA Reauthorization Act's emphasis on healthy aging and risk reduction means federal research and public health messaging will increasingly focus on strategies to delay or prevent cognitive decline, not just treat existing diagnoses.
Adding DOJ and FEMA to the Advisory Council signals a broader recognition that dementia intersects with the justice system — think guardianship, elder abuse, and financial exploitation — and with disaster preparedness, where seniors with cognitive impairment face outsized risk during emergencies and evacuations.
In practice, seniors should see these agencies' expertise gradually inform more dementia-aware protocols in courts, first-responder training, and emergency planning, though the law itself sets direction rather than mandating specific local changes overnight.
For the family members shouldering day-to-day care, the most direct benefit is stability in the research pipeline that eventually produces better treatments, diagnostic tools, and care models. The Accountability and Investment Act's protected NIH budget process is designed to accelerate that pipeline by insulating it from political swings.
Both laws also reference reducing health disparities among underrepresented populations and improving caregivers' access to resources and services, though the specifics of new programs will depend on how agencies implement the legislation in the coming years.
Given that three-quarters of caregivers report finances directly affecting care decisions, the promise of sustained, well-directed research funding is meaningful — but it's a long-term structural change, not an immediate source of financial relief for a family managing costs this month.
It's worth being clear-eyed about what these laws don't do. Neither creates a new caregiver stipend, expands Medicare or Medicaid coverage for memory care, or funds a specific new treatment. They're structural: they extend a planning framework and protect a research budget process.
The National Alzheimer's Plan itself is a coordinating document, not a service-delivery program — its impact shows up gradually, through funded research, agency coordination, and policy recommendations rather than immediate benefits a family can apply for.
Families should treat 2024's legislative wins as encouraging signals about the direction of federal commitment, while still relying on existing resources — Medicare, Medicaid, the Alzheimer's Association, and Area Agencies on Aging — for near-term help.
These new laws don't change what a family needs to do this week: get a clear diagnosis, understand the stage of disease, and start mapping out a care plan. The legislation strengthens the systems behind that work — research funding, interagency coordination, caregiver resources — but it doesn't replace the planning conversation happening at your own kitchen table.
Start by connecting with the Alzheimer's Association's 24/7 helpline or a local Area Agency on Aging to find caregiver support groups, respite care, and financial counseling in your area. Caring.com's 2024 dementia care study found that 75% of caregivers say finances significantly shape whether a loved one gets care at home or in a memory care facility, so building a realistic budget early matters as much as any legislation.
Keep an eye on how the expanded Advisory Council — now including the Department of Justice and FEMA — rolls out new guidance, since disaster preparedness and legal protections for people with dementia are relatively new additions to the national plan. Ask your care team or elder law attorney whether any new resources apply to your situation.
Most importantly, don't wait on federal timelines to make your own decisions. The National Plan runs through 2035, but your family's needs are immediate. Use this legislative stability as reassurance that research and coordination will continue, while you focus on the concrete steps — legal documents, care arrangements, financial planning — that protect your loved one today.
Two 2024 laws — the NAPA Reauthorization Act and the Alzheimer's Accountability and Investment Act — extend federal Alzheimer's planning through 2035 and protect NIH research funding from political interference, offering families a more stable, better-coordinated system to lean on.
In October 2024, Congress passed two bipartisan laws that reshape the federal response to Alzheimer's disease: the NAPA Reauthorization Act, which extends the National Alzheimer's Plan through 2035 and widens its advisory council, and the Alzheimer's Accountability and Investment Act, which locks in a direct NIH budget process for dementia research. Neither law hands a family a check or a bed in a memory care community tomorrow, but together they protect the funding pipeline and federal coordination that shape research breakthroughs, caregiver programs, and care standards for years to come. Families dealing with a new diagnosis should treat these laws as background reassurance, not a substitute for building their own care plan, cost strategy, and support network today.
If your loved one shows new confusion, wandering, medication errors, or a sudden change in ability to manage finances, don't wait for a scheduled checkup. Contact their physician promptly, and if there's any safety risk — leaving the stove on, getting lost, aggressive behavior — reach out to the Alzheimer's Association helpline or local emergency services the same day.